Bristol Myers Squibb (BMY) Other Non-Current Liabilities (2009 - 2026)
Bristol Myers Squibb (BMY) reported Other Non-Current Liabilities of $4.34 billion for Q2 2026, down 12.2% from $4.94 billion a year earlier and down 10.6% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Other Non-Current Liabilities of $5.04 billion, up 12.8% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $4.47 billion in FY2024 (-30.4%), $6.42 billion in FY2023 (-2.6%), $6.59 billion in FY2022 (-10.1%) and $7.33 billion in FY2021 (-5.7%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q3 2019.
- Year over year, Other Non-Current Liabilities gained in three of the last eight quarters, with an average decline of 8.0%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q3 2025 (growth of 15.5%); the low point was Q1 2025 (a decline of 33.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.85 billion (Q1 2026), $5.04 billion (Q4 2025) and $5.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.61 Bn | 1,122.20 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.26 Bn | 542.79 Bn | 17.26 Bn |
| 3 | AbbVie | 512.23 Bn | 485.34 Bn | 12.70 Bn |
| 4 | Merck | 365.41 Bn | 319.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.24 Bn | 261.23 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn |
| 7 | Amgen | 234.57 Bn | 189.97 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.81 Bn | 167.01 Bn | 6.22 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 125.59 Bn | 76.87 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.34 Bn |
| Mar 31, 2026 | 4.85 Bn |
| Dec 31, 2025 | 5.04 Bn |
| Sep 30, 2025 | 5.46 Bn |
| Jun 30, 2025 | 4.94 Bn |
| Mar 31, 2025 | 4.48 Bn |
| Dec 31, 2024 | 4.47 Bn |
| Sep 30, 2024 | 4.73 Bn |
| Jun 30, 2024 | 4.99 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 6.42 Bn |
| Sep 30, 2023 | 6.20 Bn |
| Jun 30, 2023 | 5.90 Bn |
| Mar 31, 2023 | 6.66 Bn |
| Dec 31, 2022 | 6.59 Bn |
| Sep 30, 2022 | 6.69 Bn |
| Jun 30, 2022 | 6.64 Bn |
| Mar 31, 2022 | 7.31 Bn |
| Dec 31, 2021 | 7.33 Bn |
| Sep 30, 2021 | 7.52 Bn |
API Access
Bristol Myers Squibb Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();